News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
Vaccines
SOUTH AFRICA: Two women unlock possible key to HIV vaccine

Two South African women may have helped unlock the key to a vaccine to rid the world of one its deadliest epidemics, according to new research released by South African HIV experts. Because they acquired HIV while taking part in large-scale clinical trials, researchers were able to follow them for years, discovering in the process that their bodies produce rare antibodies found in only one out of every five HIV patients.

Published
23 October 2012
From
IRIN Plus News
Pharmaceutical industry
GlaxoSmithKline To Make Clinical Trial Data Available To Other Researchers

GlaxoSmithKline (GSK) CEO Andrew Witty "said on Thursday detailed data from its clinical trials would be made available to other researchers," Reuters reports, adding, "That would include anonymized patient-level results that sit behind clinical trials of approved and failed drugs"

Published
15 October 2012
From
Kaiser Daily Global Health Policy Report
TB treatment
Launch of the Good Participatory Practice Guidelines for TB Drug Trials

The Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens initiative launches guidelines that will facilitate the involvement of communities and participants in the conduct of TB drug trials.

Published
04 October 2012
From
Critical Path to TB Drug Regimens
Pharmaceutical industry
The drugs don't work: a modern medical scandal

The doctors prescribing the drugs don't know they don't do what they're meant to. Nor do their patients. The manufacturers know full well, but they're not telling.

Published
25 September 2012
From
The Guardian
Clinical trials
Ethics of hepatitis C drug pitch questioned

Ethicists said that the doctor's comments appear to have breached ethics principles by potentially leaving his audience with outsize hope for drugs undergoing testing. Doing so, they said, was particularly striking at a moment when patients felt violated and vulnerable.

Published
25 September 2012
From
Boston Globe
HIV prevention policy
Judy Auerbach: On “Activism”

There will be another group of activists, who often are not thought of in this way, who also will populate AIDS 2012. These are what I call “scientist-activists”.

Published
08 July 2012
From
Somatosphere
Pharmaceutical industry
How Secrecy in Medical Research Harms our Health

Medical research data remain shrouded in secrecy. As a result the data is distorted and misrepresented by pharmaceutical companies launching new medicines.

Published
05 July 2012
From
Open Society Foundations
Clinical trials
How to Tell When A Drug Company Fibs About Clinical Trial Results

Interpreting clinical trial results with a skeptical eye is a crucial tool for all biotech investors, so apply critical skills universally whenever a drug or biotech company tries to convince you that its drug works. Hopefully, you'll find most companies are telling the truth, but sadly and too often, bullish pronouncements about boffo clinical trial data are just spin.

Published
04 July 2012
From
The Street
Clinical trials
Nobel fight over African HIV centre

Laureates question choice of Luc Montagnier as interim scientific director.

Published
20 June 2012
From
Nature
Clinical trials
PrEP: time to rethink prevention, effectiveness and ethics?

Most remarkable about the growing interest in PrEP is the exclusion of the social sciences from major forums where this work is taking place. But this absence also raises the question of what sort of social research should be called upon in response to the biomedicalisation of the epidemic.

Published
19 June 2012
From
Somatosphere
← Prev12345...8Next →

Filter by country